From Molecules to Medicine
Development of a New Drug
- Health at Bayer
-
Pharmaceuticals
- Treatment Areas
- Innovation & Technologies
- Cell and Gene Therapy
-
Sustainability
- Patient Access Charter
- Leadership Perspective
- Strengthening Healthcare Access
-
Empowering Women, Globally
- Boosting Family Planning Usage through Digital Channels
- Capacity building: Addressing Root Causes through Partnerships
- Impact at Scale: The Challenge Initiative
- Promoting Awareness: World Contraception Day (WCD) & the Your Life Campaign
- Providing Accessible and Affordable Contraceptives
- Enabling Family Planning in Humanitarian Settings
- Fighting Neglected Tropical Diseases
- Moving Non-Communicable Diseases Care Forward
- Ensuring a Sustainable Product Supply
- Delivering Better Cancer Care
- Transparency
- News & Stories
- Personal Health
- Report a Side Effect
- Medical Counterfeits
The benefits and risks of drugs are evaluated, confirmed, and double-checked
Drug development is a very complex job, which is strictly regulated. Before a new medicine hits the pharmacy shelves, scientists and physicians spend ten to twelve years comprehensively investigating the drug candidate, first in the lab and then in healthy volunteers and finally in thousands of patients who volunteer to participate in clinical studies. All the data – roughly 500,000 pages – are then submitted to the health authorities. Only when the experts at the regulatory authorities have carefully reviewed all the information and approved the drug, is it available for you, the patient.
Want to witness the journey in time lapse in an entertaining way?
Further Links